Solian is a medication with the active ingredient Amisulpride. It is also known by alternative names such as deniban and amisulpiride. It is used to treat mental health conditions like schizophrenia, helping to manage symptoms like hallucinations and delusions.
A pack of Solian can cost anywhere between £2.06 and £3.52. The exact price depends on pack measurements and active ingredient density (10 or 270 mg).
The active ingredient in Solian is amisulpride. It belongs to the class of medications known as antipsychotics, particularly atypical antipsychotics.
Amisulpride primarily functions by blocking certain receptors in the brain. It acts on dopamine receptors D2 and D3, which play a role in mood and behavior regulation.
Amisulpride has an oral bioavailability of approximately 48%. After oral administration, peak plasma concentrations occur within 1 to 4 hours. The half-life of amisulpride is approximately 12 hours. It is mainly excreted unchanged by the kidneys.
Solian is indicated for the treatment of acute and chronic schizophrenic disorders. It is prescribed to manage both positive symptoms, such as hallucinations and delusions, and negative symptoms, such as emotional and social withdrawal. It may also be useful in cases of bipolar disorder where psychotic features are present.
The typical starting dose for adults is between 400 mg to 800 mg per day, which can be adjusted based on the patient’s response and clinical condition. Solian is usually administered orally, either once daily or in divided doses. The maximum recommended dose should not exceed 1200 mg per day.
Solian is contraindicated in patients with a known hypersensitivity to amisulpride. It should not be used in individuals with prolactin-dependent tumors, phaeochromocytoma, or by those with known QT interval prolongation. Additionally, severe renal impairment is a contraindication to its use.
Amisulpride may interact with other medications that prolong the QT interval, increasing the risk of cardiac arrhythmias. Combining Solian with other central nervous system depressants can enhance sedative effects. Concomitant use with antihypertensive drugs may result in enhanced hypotensive effects.
Common side effects include insomnia, anxiety, and agitation. Gastrointestinal disturbances such as nausea and constipation may also occur. Extrapyramidal symptoms like tremor and rigidity can develop, especially at higher doses. Weight gain and hyperprolactinemia have been reported with sustained use.
In elderly patients, Solian should be used with caution, and doses should typically be lower. Patients with mild to moderate renal impairment may require dose adjustments. Amisulpride is not recommended during pregnancy unless absolutely necessary and should be used with caution during breastfeeding.
Overdose of Solian can lead to symptoms such as drowsiness, sedation, coma, and hypotension. Management involves symptomatic and supportive treatment. Activated charcoal may help reduce absorption if administered shortly after ingestion. Cardiac monitoring is recommended due to the risk of QT interval prolongation.
Solian should be stored at room temperature, between 15°C and 30°C (59°F and 86°F). Keep the medication in its original container, protected from light and moisture. Ensure that it is kept out of reach of children.
Regular monitoring of blood glucose levels is recommended due to the risk of hyperglycemia. Periodic assessment of liver function tests and complete blood counts may be necessary. Monitoring for signs of potential cardiac arrhythmias through ECG readings could be important in long-term therapy.
Patients should be counseled to avoid activities requiring full mental alertness until they understand how Solian affects them. They should be advised to rise slowly from sitting or lying positions to prevent orthostatic hypotension. Discuss the risk of weight gain and encourage a balanced diet and regular exercise.
Discontinuation of Solian should be done gradually to prevent withdrawal symptoms such as nausea, vomiting, and insomnia. A slow tapering off the dose is recommended over a period of several weeks, under medical supervision.